Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), an innovative cancer drug discovery and development company, is focused on discovering, developing, and delivering best-in-class medicines designed to treat cancer and related conditions. The company leverages its proven scientific expertise and passion for developing novel small molecule drugs designed to target emerging cancer pathways. Infinity’s two most advanced programs are examples of its innovative approach to oncology drug discovery and development. For further information, visit the Company’s web site at www.infi.com.
- 17 years ago
QualityStocks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
Tags Rodman & Renshaw
Related Post
-
Xeriant Inc. (XERI) Builds Innovation Ecosystem Focused on Advanced Technologies, Commercialization
Xeriant is focused on acquiring, developing and commercializing transformative technologies with applications across multiple industrial…
-
TechForce Robotics Inc. (NGTF): Proving Practical Solutions for the Industry’s Fatigued Areas
Hospitality operators are adopting robotics to target the most physically demanding jobs in hotels, venues,…
-
Drilling Assay Results Boost Deposit Potential, Demonstrates High-Grade Gold Intervals and Continuity for LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF), Setting Stage for Forthcoming PEA
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may…